Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
04 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/valo-health-completes-enrollment-of-opl-0401-phase-2-study-for-the-treatment-of-diabetic-retinopathy-302078247.html
16 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/valo-health-announces-changes-to-its-board-of-directors-and-leadership-team-302036151.html
14 Dec 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/valo-health---fda-collaborative-study-in-human-cardiac-tissues-demonstrates-potential-to-predict-clinical-efficacy-of-cardiac-contractility-modulation-devices-to-treat-heart-failure-301702596.html
16 Nov 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/valo-health-to-participate-in-piper-sandlers-34th-annual-healthcare-conference-301680766.html
18 Aug 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/valo-health-announces-first-patient-dosed-in-the-opl-0401-phase-2-study-of-an-oral-rock12-inhibitor-for-the-treatment-of-non-proliferative-diabetic-retinopathy-301608447.html
27 Apr 2022
// BUSINESSWIRE
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?